Information:
Fel:
ID
44278
Beskrivning
Efficacy and Safety Study of Second-Line Treatment for Hypertension With Autosomal Dominant Polycystic Kidney Disease(ADPKD); ODM derived from: https://clinicaltrials.gov/show/NCT00890279
Länk
https://clinicaltrials.gov/show/NCT00890279
Nyckelord
Versioner (2)
- 2018-05-12 2018-05-12 -
- 2021-09-20 2021-09-20 -
Rättsinnehavare
See clinicaltrials.gov
Uppladdad den
20 september 2021
DOI
För en begäran logga in.
Licens
Creative Commons BY 4.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
Eligibility Kidney, Polycystic, Autosomal Dominant NCT00890279
Eligibility Kidney, Polycystic, Autosomal Dominant NCT00890279
- StudyEvent: Eligibility
Similar models
Eligibility Kidney, Polycystic, Autosomal Dominant NCT00890279
- StudyEvent: Eligibility
Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
Polycystic Kidney Disease, Autosomal Dominant
Item
adpkd patients
boolean
C0085413 (UMLS CUI [1])
Blood pressure measurement | Outpatient
Item
blood pressure measured at out-patient setting is above 120/80 mmhg
boolean
C0005824 (UMLS CUI [1])
C0029921 (UMLS CUI [2])
C0029921 (UMLS CUI [2])
Age
Item
age between 20 and 60 years old
boolean
C0001779 (UMLS CUI [1])
Estimated Glomerular Filtration Rate
Item
egfr more than 30 ml/min/1.73m2
boolean
C3811844 (UMLS CUI [1])
Informed Consent
Item
patients give informed consent
boolean
C0021430 (UMLS CUI [1])
Cardiovascular Disease Severe | Liver disease Severe
Item
patients with severe cardiovascular and hepatic disorders
boolean
C0007222 (UMLS CUI [1,1])
C0205082 (UMLS CUI [1,2])
C0023895 (UMLS CUI [2,1])
C0205082 (UMLS CUI [2,2])
C0205082 (UMLS CUI [1,2])
C0023895 (UMLS CUI [2,1])
C0205082 (UMLS CUI [2,2])
Central nervous system vascular disorders Complications
Item
patients with complications of central nervous vascular disorders
boolean
C0851452 (UMLS CUI [1,1])
C0009566 (UMLS CUI [1,2])
C0009566 (UMLS CUI [1,2])
Breast Feeding | Childbearing Potential Contraceptive methods Absent
Item
women who are breast feeding and females of childbearing potential who are not using acceptable contraceptive methods
boolean
C0006147 (UMLS CUI [1])
C3831118 (UMLS CUI [2,1])
C0700589 (UMLS CUI [2,2])
C0332197 (UMLS CUI [2,3])
C3831118 (UMLS CUI [2,1])
C0700589 (UMLS CUI [2,2])
C0332197 (UMLS CUI [2,3])
Study Subject Participation Status
Item
patients currently engaging in other experimental protocol
boolean
C2348568 (UMLS CUI [1])
Intracranial Aneurysm
Item
patients with intracranial aneurysma
boolean
C0007766 (UMLS CUI [1])
Patient need for Diuretics
Item
patients who must use diuretics
boolean
C0686904 (UMLS CUI [1,1])
C0012798 (UMLS CUI [1,2])
C0012798 (UMLS CUI [1,2])
Hypersensitivity Candesartan | Hypersensitivity Cilnidipine
Item
allergic patients to candesartan or cilnidipine
boolean
C0020517 (UMLS CUI [1,1])
C0717550 (UMLS CUI [1,2])
C0020517 (UMLS CUI [2,1])
C0378675 (UMLS CUI [2,2])
C0717550 (UMLS CUI [1,2])
C0020517 (UMLS CUI [2,1])
C0378675 (UMLS CUI [2,2])
Hypertensive disease Control | Pharmaceutical Preparations Study Protocol Absent
Item
patients whose hypertension is not controlled by medication of this protocol
boolean
C0020538 (UMLS CUI [1,1])
C0243148 (UMLS CUI [1,2])
C0013227 (UMLS CUI [2,1])
C2348563 (UMLS CUI [2,2])
C0332197 (UMLS CUI [2,3])
C0243148 (UMLS CUI [1,2])
C0013227 (UMLS CUI [2,1])
C2348563 (UMLS CUI [2,2])
C0332197 (UMLS CUI [2,3])